Skip to main content

Insulin device maker brings in $115M to launch J&J-licensed product

Marlborough-based CeQur, a maker of insulin delivery devices, has raised $115 million in what it's calling a Series C5 round as it gears up to launch its wearable insulin injector later this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.